JUNS vs XEL · rev $21.8K vs P/E 20, $39.33B cap
Jupiter Neurosciences, Inc. Common Stock (JUNS) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
XEL does not have a complete income-statement cache yet.
JUNS currently screens at market cap $10.0M. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the JUNS and XEL stock pages for the full models.
Not investment advice.